Higher health-care costs force financial trade-offs: Investors 'worry about all these moving pieces,' top advisor says

Employer-sponsored health benefit costs are set to jump materially, with Mercer forecasting a 6.7% rise in 2026 that would push average total cost per employee above $18,500, the largest increase in 15 years. KFF data show family premiums rose 6% this year versus 2.7% inflation and 4% wage growth, while KeyBank survey results indicate rising health costs are the top expense pressure for 21% of adults (30% of those earning $100k+), driving 26% to tap emergency savings and 12% to cut retirement contributions. Higher utilization, an aging population and possible employer changes to deductibles are cited as drivers; planners recommend maximizing FSAs/HSAs (2026 limits: FSA $3,400; HSA $4,400 individual/$8,750 family plus $1,000 catch-up) and reassessing budgets and tax withholding to preserve liquidity.

Analysis

Market structure: Rising employer-sponsored premiums (projected +6.7% in 2026) and higher average deductibles (family ~$4,063) shift more cost to consumers, benefiting insurers and PBMs with pricing power (UNH, CVS, CI) while pressuring small employers, regional carriers and discretionary retailers. Chronic-disease-driven utilization (aging + diabetes/CVD) implies inelastic demand for branded chronic meds (MRK, JNJ) and steadier cashflows for integrated payor-provider models; hospitals face mixed outcomes as higher utilization meets tougher payer negotiations.

Risk assessment: Key tail risks include aggressive federal price negotiation or expansion of Medicare authority (policy shock within 6–18 months) and employer-driven migration to high-deductible plans causing delayed elective care (6–12 months). Hidden dependencies: rising HSA/FSA flows increase assets under custody (benefitting HQY and custodians) but also concentrate counterparty credit risk if self-funded employer pools underperform. Catalysts: 2026 renewal season (Q3–Q4 2025), insurer earnings (UNH/CVS quarterly), and pending legislation around drug pricing.

Trade implications: Favor health insurers/PBM long exposure sized 2–3% positions (UNH, CVS, CI) financed by trimming consumer discretionary (-2–4% XLY). Implement pair: long UNH vs short HCA equal-dollar to capture insurer pricing power vs provider margin squeeze. Use options to express view: buy 6–9 month UNH call spreads (buy 10% ITM/OTM depending on spot) to cap premium with expected earnings tailwinds; rotate into 5–10y TIPS (TIP) if CPI stays sticky above 3.5%.

Contrarian angles: Consensus underestimates HSA custodial winners (HQY); the market overprices regulatory risk on PBMs — short-term political headlines may compress multiples but underlying volume/pricing resilience persists. Historical parallel: 2000s sustained medical inflation favored diversified payors; if utilization acceleration continues, investors should prefer scale/vertical integration over standalone hospitals or small carriers.

Key Decisions for Investors

• Establish a 2.5% long position in UnitedHealth (UNH) over next 4–8 weeks; set stop-loss at -10% and target +12–18% over 6–12 months on expected premium-driven revenue and margin expansion at renewals.
• Initiate a 2–3% long position in CVS Health (CVS) or Cigna (CI) to capture PBM + insurer upside; prefer CVS if pharmacy retail tailwinds are material. Trim position if regulatory headlines increase probability of punitive legislation above 30% likelihood (monitor bills/events).
• Implement a pair trade: long UNH (2%) vs short HCA Healthcare (HCA) (2%) dollar-neutral. Rationale: insurer pricing power vs provider reimbursement pressure; re-evaluate after 2 quarterly earnings cycles or if HCA EBITDA margin expands >150 bps.
• Buy a 6–9 month UNH call spread sized to 0.5–1.0% of portfolio (buy nearer-term 5–10% OTM calls, sell 15–20% OTM) to capture upside while capping premium; roll or realize on positive 2026 renewal commentary.
• Allocate 3–5% of fixed-income sleeve to TIPS (TIP ETF or direct) in 5–10y maturities if headline CPI stays >3.5% on two consecutive monthly prints, as persistent health inflation raises rate-floor risk.